Aptadir Therapeutics (Aptadir), a biotech company developing RNA inhibitor-based therapeutics for treating intractable cancers and genetic conditions, ...

Certain types of biochemical processes can impair the immune system's ability to recognize and kill cancer cells. Purdue University's W. Andy Tao and his associates have developed a new way to study ...

Researchers at Case Western Reserve University have discovered molecules that present the potential to drive the development of gastric cancer-among the world's deadliest forms of the disease.

New findings show how thioesters could have been built, an important step to providing the energy needed for protein ...

These are a class of small molecules composed of only 20 to 24 nucleotides (the A, C, G, U letters of the genome), and they play a key role in how cells work. More on the 2024 Nobel prizes: ...

Over the next four years, Kasinski’s project will advance ligand-targeted miRNA mimic conjugates. These engineered molecules restore tumor-suppressing miRNAs and deliver them directly to cancer cells, ...

Circular Genomics Joins Lilly Gateway Labs in San Diego to Develop Its Best-In-Class Circular RNA Platform for the Diagnosis and Prognosis of Alzheimer's Disease PR Newswire SAN DIEGO, March 17, 2025 ...

Researchers at the Regensburg Center for Biochemistry (RCB) and the Regensburg Center for Ultrafast Nanoscopy (RUN) at the ...

About Circular Genomics Circular Genomics is the world-leading developer of circular RNA-based precision medicine tools, data and diagnostics for precision neurology and psychiatry.